171 related articles for article (PubMed ID: 37457886)
21. Downregulation of SLC9A8 Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer Cells via the IL6-JAK1/STAT3 Signaling Pathway.
Liu W; Geng C; Li X; Li Y; Song S; Wang C
Dig Dis Sci; 2023 May; 68(5):1873-1884. PubMed ID: 36583805
[TBL] [Abstract][Full Text] [Related]
22. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
23. Prognosis significance and potential association between ALDOA and AKT expression in colorectal cancer.
Xu M; Xi S; Li H; Xia Y; Mei G; Cheng Z
Sci Rep; 2024 Mar; 14(1):6488. PubMed ID: 38499636
[TBL] [Abstract][Full Text] [Related]
24. Loss of HACE1 promotes colorectal cancer cell migration via upregulation of YAP1.
Zhou Z; Zhang HS; Zhang ZG; Sun HL; Liu HY; Gou XM; Yu XY; Huang YH
J Cell Physiol; 2019 Jun; 234(6):9663-9672. PubMed ID: 30362561
[TBL] [Abstract][Full Text] [Related]
25. Aldolase A overexpression is associated with poor prognosis and promotes tumor progression by the epithelial-mesenchymal transition in colon cancer.
Ye F; Chen Y; Xia L; Lian J; Yang S
Biochem Biophys Res Commun; 2018 Mar; 497(2):639-645. PubMed ID: 29453983
[TBL] [Abstract][Full Text] [Related]
26. miR-122-5p Inhibits the Proliferation, Invasion and Growth of Bile Duct Carcinoma Cells by Targeting ALDOA.
Xu Z; Liu G; Zhang M; Zhang Z; Jia Y; Peng L; Zhu Y; Hu J; Huang R; Sun X
Cell Physiol Biochem; 2018; 48(6):2596-2606. PubMed ID: 30121648
[TBL] [Abstract][Full Text] [Related]
27. Aldolase A promotes cervical cancer cell radioresistance by regulating the glycolysis and DNA damage after irradiation.
Zhou J; Lei N; Qin B; Chen M; Gong S; Sun H; Qiu L; Wu F; Guo R; Ma Q; Li Y; Chang L
Cancer Biol Ther; 2023 Dec; 24(1):2287128. PubMed ID: 38010897
[TBL] [Abstract][Full Text] [Related]
28. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
Tao Y; Han T; Zhang T; Ma C; Sun C
Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
[TBL] [Abstract][Full Text] [Related]
29. The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68.
Wang X; Yu H; Sun W; Kong J; Zhang L; Tang J; Wang J; Xu E; Lai M; Zhang H
Mol Cancer; 2018 Jul; 17(1):110. PubMed ID: 30064438
[TBL] [Abstract][Full Text] [Related]
30. CSRP2 suppresses colorectal cancer progression
Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
[TBL] [Abstract][Full Text] [Related]
31. Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia.
Niu Y; Lin Z; Wan A; Sun L; Yan S; Liang H; Zhan S; Chen D; Bu X; Liu P; Chen C; He W; Lu X; Wan G
Hepatology; 2021 Sep; 74(3):1461-1479. PubMed ID: 33813748
[TBL] [Abstract][Full Text] [Related]
32. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
[TBL] [Abstract][Full Text] [Related]
33. MKL-1-induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA-mediated glycolysis.
Wang J; Zhang HM; Dai ZT; Huang Y; Liu H; Chen Z; Wu Y; Liao XH
Sci Rep; 2022 Dec; 12(1):21283. PubMed ID: 36494481
[TBL] [Abstract][Full Text] [Related]
34. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of the ALDOA/DNA-PK/p53 pathway by dietary restriction suppresses tumor growth.
Ma D; Chen X; Zhang PY; Zhang H; Wei LJ; Hu S; Tang JZ; Zhou MT; Xie C; Ou R; Xu Y; Tang KF
Oncogene; 2018 Feb; 37(8):1041-1048. PubMed ID: 29084207
[TBL] [Abstract][Full Text] [Related]
36. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
37. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.
Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T
J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761
[TBL] [Abstract][Full Text] [Related]
38.
Cheng C; Huang Z; Zhou R; An H; Cao G; Ye J; Huang C; Wu D
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G841-G853. PubMed ID: 32146835
[TBL] [Abstract][Full Text] [Related]
39. CDKN2B antisense RNA 1 suppresses tumor growth in human colorectal cancer by targeting MAPK inactivator dual-specificity phosphatase 1.
Pan J; Lin M; Xu Z; Xu M; Zhang J; Weng Z; Lin B; Lin X
Carcinogenesis; 2021 Nov; 42(11):1399-1409. PubMed ID: 34436551
[TBL] [Abstract][Full Text] [Related]
40. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
